ARCHIVES

FDA Breakthrough Designation Granted to Pfizer’s Palbociclib

This article is from The Cancer Letter archive.

Vol. 36 No. 4 | April 26, 2013

Download PDF Visit The Full Archive

Related Articles

Obituary: Ronald Herberman, 72, UPCI Founding Director

July 3, 2013

Upton Heads NIH Effort To Define Prevention

April 21, 1978

Letter to the Editor: Gensia Official Says No “Threat” Implied In Question Study

May 26, 1995

House and Senate Appropriators Pledge to Increase Biomedical Research Funding.

March 5, 1999

DCPC Advisors OK PA On cancer Control In Disadvantaged

June 14, 1991

Group Chairmen Propose Adding Four Trials For High Priority Status

July 6, 1990